Trial Profile

A Randomized, Within Subject Controlled, Dose Regimen Study of SLI-F06 in Healthy Volunteers for Improvement in Scar Appearance

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 31 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SLI F06 (Primary)
Indications Scars; Wounds
Focus Therapeutic Use
Sponsors Scarless Laboratories

Most Recent Events

24 Jul 2023 Planned End Date changed from 25 Oct 2023 to 25 Oct 2024.
24 Jul 2023 Planned primary completion date changed from 25 Jul 2023 to 25 Jul 2024.
24 Aug 2022 According to ClinicalTrials.gov record, protocol has been amended as change in timeframe for primary endpoint from 6months to 1,3,6 and 9 months.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com